China vs Latin America & Caribbean: Immunization, measles second dose
China
95.0%
in 2024
Latin America & Caribbean
69.3%
in 2024
China rank
33rd
Latin America & Caribbean rank
31st
Immunization, measles second dose over time
- China
- Latin America & Caribbean
How they compare
China currently reports 95.0% against 69.3% in Latin America & Caribbean, a difference of 25.7%.
That makes China's figure about 1.4 times Latin America & Caribbean's.
Across all 20 years both countries report, China has been ahead every year.
China ranks 33rd and Latin America & Caribbean ranks 31st of 178 countries.
China has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | Latin America & Caribbean | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.6% | 55.1% | 37.5% | China |
| 2010s | 98.9% | 68.2% | 30.7% | China |
| 2020s | 97.4% | 67.4% | 30.0% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, China or Latin America & Caribbean?
- China, at 95.0% against 69.3% in Latin America & Caribbean as of 2024.
- What is the difference in immunization, measles second dose between China and Latin America & Caribbean?
- 25.7%, with China ahead.
- How many years of comparable data are there for China and Latin America & Caribbean?
- 20 years are reported by both, from 2005 to 2024.
- How do China and Latin America & Caribbean rank globally for immunization, measles second dose?
- China ranks 33rd and Latin America & Caribbean ranks 31st of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.